Multiple sources are pointing to a new report that Merck paid Elsevier, a leading publisher, to produce several volumes of the Australasian Journal of Bone and Joint Medicine, which appeared to be a peer-reviewed journal, but was really little more than marketing material for the pharmaceutical company.
Merck and Elsevier Published Fake Journal
May 4, 2009
Share this post
2 Comments
Law Bytes
Episode 199: Boris Bytensky on the Criminal Code Reforms in the Online Harms Act
byMichael Geist
April 15, 2024
Michael Geist
April 8, 2024
Michael Geist
March 25, 2024
Michael Geist
March 18, 2024
Michael Geist
March 11, 2024
Michael Geist
Search Results placeholder
Recent Posts
- Debating the Online Harms Act: Insights from Two Recent Panels on Bill C-63
- The Law Bytes Podcast, Episode 199: Boris Bytensky on the Criminal Code Reforms in the Online Harms Act
- AI Spending is Not an AI Strategy: Why the Government’s Artificial Intelligence Plan Avoids the Hard Governance Questions
- The Law Bytes Podcast, Episode 198: Richard Moon on the Return of the Section 13 Hate Speech Provision in the Online Harms Act
- Tweets Are Not Enough: Why Combatting Relentless Antisemitism in Canada Requires Real Leadership and Action
And educational institutions subscribe to Elsevier ScienceDirect
1. Publish a fake journal with Elsevier and the like
2. Make educational institurions subscribe to Elsevier and the like
3. Tie university professors with Big Pharma
4. PROFIT!
Regarding [3], visit http://www.ahrp.org/cms/content/view/523/9/
Harvard Medical Students Rebel Against Big Pharma
“The students say they worry that pharmaceutical industry scandals in recent years – including some criminal convictions, billions of dollars in fines, proof of bias in research and publishing and false marketing claims – have cast a bad light on the medical profession. And they criticize Harvard as being less vigilant than other leading medical schools in monitoring potential financial conflicts by faculty members.”
Marketing material, yes, but…
The info that the publication was paid for by Merck could be inferred, if you took the time. In the item pointed to, the ONLY advertisements were from Merck (at least that was the only ones that I noticed).
However, I’d agree that it should have been specifically mentioned. Sort of like the “Medi-Facts” commercials airing these days.